BIHS Statement on NICE Guideline NG238: Cardiovascular disease: risk assessment and reduction, including lipid modification [NG238] Published: 14 December 2023.
Endorsed by the BIHS Guidelines Standing Committee and Executive Committee.
Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society
Adult hypertension referral pathway and therapeutic management: British and Irish Hypertension Society position statement.
BIHS Statement on Referral to a Hypertension Specialist
BIHS Statement on Renal Denervation (RDN) following publication of the NICE Interventional Procedures Guidance IPG754: Percutaneous transluminal renal sympathetic denervation for resistant hypertension. March 2023.
BIHS Statement on infection control in the use of BP monitoring equipment. January 2021
COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society
BIHS Statement published by the Journal of Human Hypertension January 2021
Fibromuscular dysplasia and hypertension—a statement on behalf of the British and Irish Hypertension Society
BIHS Statement published by the Journal of Human Hypertension November 2020
BIHS Statement published by the Journal of Human Hypertension April 2020
BIHS Statement published by the Journal of Human Hypertension October 2019
BIHS Statement published by the Journal of Human Hypertension April 2019
BIHS Technical Note published by the Journal of Human Hypertension April 2019
Guidance on BP monitor cuffs for use in diagnosing hypertension in obese patients.
Response to recent publicity and debate resulting from reports questioning the benefits of aspirin use in those with no history of prior CVD, including those with diabetes, particularly in the context of the known increase in risk of gastrointestinal bleeding.
The Consensus Statement was published in Heart in November 2014. The above links to the online open-access article.
It is thought that between a third and a half of all medicines prescribed for long-term conditions are not taken as recommended. ‘Simplifying the dosing regimen’ is one way of improving patient adherence as suggested by the NICE medicines adherence guidelines.